Epidemiology, Environment, and the Pathogenesis of Pediatric IBD: Lessons from Big Data

08/06/2018

Related Content

Hypertension
Hypertension in diabetes patients
Hypertension
George Bakris, MD, on Debating the New Hypertension Guidelines: Insights from the HEART iN DIABETES Conference
07/16/2018
In this video, Dr George Bakris from the Comprehensive Hypertension Center discusses his session, "Hypertension in Diabetes and Cardiovascular Disease: Goals and Guidelines - The Great Debate," at...
07/16/2018
Stress and Burnout
Stress and Burnout
Elizabeth Volkmann, MD, MS, on How I Practice Now: Using a Multidisciplinary Approach to Managing Autoimmune Disease
07/14/2020
In this video, Elizabeth Volkmann, MD, MS, talks about her experience with managing autoimmune disease during the COVID-19 pandemic, as well as her hopes for the use of telemedicine in the future.
07/14/2020
Immune System
Immune System
Genomic Test May Predict Which Patients Would Benefit Most From Checkpoint Inhibition
06/08/2017
Michael Banks, MD, discusses the new genomic test created to determine a patient's tumor mutation burden, which could help identify patients that would benefit from...
06/08/2017
Inflammatory Bowel Disease
Bruce Sands, MD
Inflammatory Bowel Disease
Bruce Sands, MD, MS, on When to Recommend a JAK Inhibitor for IBD
06/25/2019
In this video, Bruce Sands, MD, MS, from the Icahn School of Medicine at Mount Sinai, discusses when a gastroenterologist should recommend a JAK inhibitor for the treatment of ulcerative colitis.
06/25/2019
Inflammatory Bowel Disease
Siegel headshot
Inflammatory Bowel Disease
Corey Siegel, MD, on Positioning JAK Inhibitors in IBD Management
06/23/2010
In this video, Corey Siegel, MD, section chief of gastroenterology and hepatology at Dartmouth-Hitchcock Medical Center, previews his talk on positioning of JAK inhibitors and small molecules in treatment...
06/23/2010